Avenue Therapeutics, Inc. (ATXI) vs Virpax Pharmaceuticals, Inc. (VRPX)
Avenue Therapeutics, Inc. and Virpax Pharmaceuticals, Inc. are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $160.0K — 4.2× the size. Across the 7 metrics below, Avenue Therapeutics, Inc. leads on 6 and Virpax Pharmaceuticals, Inc. on 1.
Valuation
Profitability
| Metric | ATXI | VRPX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.30%) | (2,364.98%) | (57.72%) |
| Return on assets | (90.50%) | (215.80%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack